Criteria for identifying residual tumours after neoadjuvant chemotherapy of breast cancers: a magnetic resonance imaging study

We investigated magnetic resonance imaging (MRI) criteria identifying residual tumours in patients with triple-negative and human epidermal growth factor receptor type 2-positive (HER2+) breast cancer following neoadjuvant chemotherapy. Retrospectively, 290 patients were included who had undergone n...

Full description

Saved in:
Bibliographic Details
Published in:Scientific reports 2021-01, Vol.11 (1), p.634-10, Article 634
Main Authors: Kim, Yunju, Sim, Sung Hoon, Park, Boram, Chae, In Hye, Han, Jai Hong, Jung, So-Youn, Lee, Seeyoun, Kwon, Youngmi, Park, In Hae, Ko, Kyounglan, Lee, Chan Wha, Lee, Keun Seok, Kang, Han-Sung, Lee, Eun Sook
Format: Article
Language:English
Subjects:
631/67
631/67/1347
Breast cancer
Chemotherapy
Epidermal growth factor
ErbB-2 protein
Humanities and Social Sciences
Lesions
Magnetic resonance imaging
multidisciplinary
Science
Science (multidisciplinary)
Surgery
Tumors
Citations: Items that this one cites
Items that cite this one
Online Access:Get full text
Tags: Add Tag
No Tags, Be the first to tag this record!